Zobrazeno 1 - 6
of 6
pro vyhledávání: '"J B, Gerstner"'
Autor:
J N, Ingle, P A, Johnson, V J, Suman, J B, Gerstner, J A, Mailliard, J K, Camoriano, D H, Gesme, C L, Loprinzi, A K, Hatfield, L C, Hartmann
Publikováno v:
Cancer. 80(2)
It is common practice to utilize a series of different hormonal agents in the treatment of postmenopausal women who, despite disease progression, continue to be candidates for hormonal therapy on a clinical basis. Letrozole is a new highly selective
Autor:
D A, Ahlquist, H S, Wieand, C G, Moertel, D B, McGill, C L, Loprinzi, M J, O'Connell, J A, Mailliard, J B, Gerstner, K, Pandya, R D, Ellefson
Publikováno v:
JAMA. 269(10)
To define the validity of fecal blood as a marker for colorectal neoplasia in the screening setting and to compare yields by Hemoccult and HemoQuant fecal occult blood screening tests.A multicenter masked comparison of fecal blood test results agains
Autor:
J C, Buckner, L D, Brown, T L, Cascino, J B, Gerstner, J E, Krook, M W, Westberg, M, Wiesenfeld, J R, O'Fallon, B, Scheithauer
Publikováno v:
Journal of neuro-oncology. 9(3)
The purpose of this study was to determine the efficacy of 24-hour concomitant infusions of etoposide (100 mg/m2/day, days 1-3) and cisplatin (45 mg/m2/day, days 2-3) in the treatment of patients with recurrent astrocytoma. All 36 patients entered on
Autor:
C G, Kardinal, C L, Loprinzi, D J, Schaid, A C, Hass, A M, Dose, L M, Athmann, J A, Mailliard, G W, McCormack, J B, Gerstner, M F, Schray
Publikováno v:
Cancer. 65(12)
Anorexia, cachexia, and resultant weight loss are major clinical problems in a substantial proportion of patients with advanced cancer. Effective means of alleviating these problematic symptoms are lacking. Extensive clinical data demonstrate a weigh
Autor:
T E, Elliott, C G, Moertel, H S, Wieand, R G, Hahn, J B, Gerstner, L K, Tschetter, J A, Mailliard
Publikováno v:
Cancer. 65(7)
Forty-eight patients with advanced gastric cancer and measurable areas of malignant disease were treated with etoposide (130 mg/m2/day X 3 days) plus cisplatin (45 mg/m2day on days 2 and 3). Both drugs were given by constant intravenous infusion and
Autor:
Loprinzi Cl, James A. Mailliard, K. Pandya, Ralph D. Ellefson, D. A. Ahlquist, D. B. McGill, J. B. Gerstner, M. J. OʼConnell, Harry S. Wieand, Charles G. Moertel
Publikováno v:
Gastroenterology Nursing. 16:91-92